GLCC and IASLC Form Partnership to Explore Progress in Lung Cancer Treatment

GLCC and IASLC Form Partnership to Explore Progress in Lung Cancer Treatment

Patient Advocacy & Survivorship
Aug 22, 2019
GLCC_IASLC_partnership
Posted: August 22, 2019

The Global Lung Cancer Coalition (GLCC) and the IASLC have formed a partnership to explore the progress that has been made in lung cancer treatment. Through a series of interviews with international experts across different dimensions of lung cancer, the IASLC and GLCC have been looking at what has changed in the past decade, what developments are coming, and what this means for people diagnosed with lung cancer.

The interviews include lung cancer advocates, as well as specialists in epidemiology, lung cancer screening, pathology, specialist nursing, pulmonary medicine, surgery, medical oncology, immuno-oncology, thoracic medicine, and tobacco control. Many of the experts featured will speak at the IASLC 2019 World Conference on Lung Cancer, and the IASLC and GLCC will be sharing their perspectives throughout the conference.

The full set of interviews are available on the GLCC website.

Share